GNRSU $0.000001 Jan 2026: Greenrose Holding (PNK) top loser risks
The GNRSU stock tumbled to $0.000001 on 16 Jan 2026 in US regular trading, making The Greenrose Holding Company Inc. one of the session’s top losers. We note a one-day change of -99.99933% and a tiny traded volume of 145 shares on the PNK exchange in the United States. GNRSU stock shows extreme illiquidity against a year high of $0.151 and a prior close of $0.15, suggesting corporate action or market microstructure moves drove the drop. We unpack valuation, liquidity, and short-term outlook below.
GNRSU stock market snapshot and price action
GNRSU stock closed at $0.000001 on 16 Jan 2026 on the PNK exchange in the United States. The recorded one-day change is -99.99933% versus the previous close of $0.15. Volume for the session was 145 shares, with average volume not reported, signaling very thin trading.
A single-session collapse this large usually reflects low liquidity, corporate restructuring, reverse splits or administrative trading events rather than a steady sell-off. We link the real-time quote to the company site for filings and updates: Greenrose website.
GNRSU stock valuation and financial snapshot
Public metrics show GNRSU with market cap reported at $13.00 and shares outstanding 12,853,627. Trailing EPS is 3.10 and the reported PE ratio is effectively near zero due to the price change, an anomaly driven by the collapsed share price. Book value per share is 4.30, while cash per share is 0.56.
Key ratios highlight stress: current ratio of 0.21, debt to equity 1.57, and days of inventory on hand 439.24. These figures show working capital pressure and inventory inefficiency in the drug manufacturers – specialty & generic sector context.
Liquidity, technicals and trading risks for GNRSU stock
GNRSU stock shows extreme liquidity risk: day low and high both $0.000001, and avg price levels (50- and 200-day) at $0.15. Such disparity indicates stale or one-off prints. Average volume is not available, increasing execution risk for larger orders.
Technical indicators are unreliable here. Price discovery for GNRSU on PNK can be distorted by spreads, OTC reporting, or administrative moves. Investors face high slippage and market access constraints.
Drivers behind the GNRSU stock drop and news context
No public earnings announcement coincides with this intraday collapse, and Greenrose lists no immediate press releases tied to the move. Thin trading and administrative actions, such as delisting threats or corporate restructurings, commonly produce abrupt prints like this on PNK.
We also track official sources for updates. For OTC market data and filings, see the OTC Markets page for GNRSU: OTCMarkets GNRSU overview.
Meyka AI grade, analysis and GNRSU stock forecast
Meyka AI rates GNRSU with a score out of 100: 63.15 | Grade: B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, industry peers, financial growth, key metrics, and analyst consensus.
Meyka AI’s forecast model projects a 12-month reference price of $0.01 versus the current $0.000001. That implies a model-based upside of approximately 999900.00% from the present print. Forecasts are model-based projections and not guarantees. These estimates are sensitive to corporate filings, liquidity restoration, and sector recovery in healthcare cannabis markets.
Catalysts, sector context and risk management for GNRSU stock
Sector performance in healthcare and specialty/generic drug makers can influence GNRSU, but company-specific items will dominate price moves at this microcap level. Catalysts that could matter include updated SEC filings, financing, or operational news from Greenrose.
We advise tight risk controls: position sizing, limit orders, and monitoring official filings. For investors tracking GNRSU stock, low liquidity and possible corporate events elevate downside risk and execution uncertainty.
Final Thoughts
Key takeaways on GNRSU stock: The Greenrose Holding Company Inc. hit $0.000001 on 16 Jan 2026 on PNK with a -99.99933% move and 145 shares traded, marking it among the session’s top losers. Financials show book value per share $4.30, EPS 3.10, and strains in working capital with a current ratio 0.21. Meyka AI rates GNRSU with a score out of 100 at 63.15 (Grade B, Suggestion: HOLD). Meyka AI’s forecast model projects $0.01, implying a model-based upside near 999900.00% from the current print; forecasts are model-based projections and not guarantees. Given thin liquidity, reporting gaps, and unusual price anomalies, we treat GNRSU as a high-risk microcap trade. Monitor official filings, OTC market notices, and any company press release before adjusting exposure. We use Meyka AI’s real-time tools to flag updates and recommend strict limits on position size and entry price.
FAQs
What caused the GNRSU stock drop on 16 Jan 2026?
The GNRSU stock collapse to $0.000001 reflects extreme illiquidity and likely an administrative or corporate event. There was no public earnings release. Thin OTC trading and reporting anomalies often produce such moves.
What is Meyka AI’s view on GNRSU stock?
Meyka AI rates GNRSU with a score out of 100 at 63.15 (Grade B, Suggestion: HOLD). The model notes liquidity risk and values the stock conditionally until clearer filings appear.
Is there a realistic price target for GNRSU stock?
Meyka AI’s forecast model projects a 12-month reference price of $0.01 versus the current $0.000001. This is a model projection and not a guarantee; it depends heavily on company actions and liquidity restoration.
How should investors manage GNRSU stock risk?
Treat GNRSU as a high-risk microcap. Use limit orders, small position sizes, and closely monitor official filings, OTC notices, and the company website for material updates.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
